Esperion治療ESPR

那斯達克 · USD
1.92
-0.10
(-4.95%)
收盤 04/22 03:59 (UTC+8)
盤後 
1.92 
1.92 
(0.00%)
04/22 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.34
  • 0.32
  • 1.38
  • 0.74
  • 0.52
  • 0.69
  • 0.65
  • 0.82
  • 0.87
  • 1.68
icon
  • 31.73
  • -5.06
  • 327.09
  • -46.39
  • -30.07
  • 33.86
  • -5.96
  • 26.76
  • 5.98
  • 92.93
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
168,446
87,309
82,385
64,995
69,113
51,632
73,834
137,735
32,250
33,969
營業成本
27,85441,28928,54331,53825,63117,28615,60910,07511,45213,377
營業毛利
140,592
46,020
53,842
33,457
43,482
34,346
58,225
127,660
20,798
20,592
營業費用
55,35955,97946,747-----63,16548,125
研發費用
13,92614,1317,23812,55710,97710,39711,46113,40317,74214,885
推銷及管理費用
41,43341,84839,50942,99636,92539,97544,18541,98845,42333,240
非經常性項目費用
----------
其他營業費用
----------
營業利益
85,233
-9,959
7,095
-22,096
-4,420
-16,026
2,579
72,269
-42,367
-27,533
其他收入及費用
1,0756776661,072-4761,584-50,7812,7771,0801,278
利息費用
22,63622,05120,48619,43116,42215,08213,72314,02415,05714,995
稅前純益
63,672
-31,333
-12,725
-40,455
-21,318
-29,524
-61,925
61,022
-56,344
-41,250
所得稅
1,841---------
稅後純益
61,831
-31,333
-12,725
-40,455
-21,318
-29,524
-61,925
61,022
-56,344
-41,250
基本每股稅後盈餘(元)
0.26-0.16-0.02-0.21-0.11-0.15-0.330.36-0.50-0.37
稀釋每股稅後盈餘(元)
0.32-0.16-0.06-0.21-0.11-0.16-0.350.34-0.50-0.34
基本平均股數(千股)
236682.00200736.00197546.00196127.00195566.00194930.00188793.00169258.00112403.00111869.00
稀釋平均股數(千股)
284573.00200736.00197546.00196127.00195566.00194930.00188793.00189641.00112403.00111869.00
還原基本每股稅後盈餘(元)
0.26-0.16-0.02-0.21-0.11-0.15-0.330.36-0.50-0.37
還原稀釋每股稅後盈餘(元)
0.32-0.16-0.06-0.21-0.11-0.16-0.350.34-0.50-0.34
還原基本平均股數(千股)
236,682200,736197,546196,127195,566194,930188,793169,258112,403111,869
還原稀釋平均股數(千股)
284,573200,736197,546196,127195,566194,930188,793189,641112,403111,869
EBITDA(千元)
86,975-8,4098,608-20,299-4,697-13,969-47,75075,483-40,850-25,802

大家都在看

HOT